Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

1126282

	registered interest
	date	13/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Patients: Transport
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what proportion of funding provided for in the NHS Long Term Plan he plans to allocate to non-emergency patient transport home after hospital attendance.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	253566
	answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The funding of non-emergency patient transport services is a matter for local National Health Service commissioners.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 21/05/2019 10:55:42 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4079 label Biography information for Julian Sturdy

1122725

	registered interest
	date	24/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Human Papillomavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to establish programme for the roll-out of the HPV vaccine for boys to ensure parity of take-up with the girls' HPV programme.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	247023
	answer	answer is ministerial correction date of answer 03/05/2019 answer text <p>Preparation to implement the extension of the human papillomavirus (HPV) vaccination programme to boys is progressing well. NHS England has carried out a series of assurance surveys to assess the preparedness of the system for the extension of the HPV vaccination programme to boys, specifically covering the service provision, delivery, data collection and coverage. The outcome of that exercise has shown that roll-out is on track for the 2019/20 academic year.</p><p>Public Health England is undertaking research with families and parents of young boys to ensure that we are able to communicate the benefits of the HPV vaccine and ensure parity with the girls’ programme.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 03/05/2019 13:17:12 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4079 label Biography information for Julian Sturdy

1111007

	registered interest
	date	10/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce rates of breast cancer in women with BRCA 1 and 2 genes.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	243438
	answer	answer is ministerial correction date of answer 17/04/2019 answer text <p>NHS England commissions breast cancer screening services, according to the published national service specifications. The Breast Cancer Screening Programme service specification includes provision for the surveillance of high risk women for early detection of breast cancer (including those with the BRCA 1 and 2 genes) and timely referral to treatment as appropriate. Specifically, following an assessment by specialised services, and referral from a genetics or oncology service, high risk women who meet the eligibility criteria (as outlined in the published guidance) will be included in the screening programme at a younger age and according to different protocols to the general population.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/04/2019 12:18:14 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4079 label Biography information for Julian Sturdy

1111006

	registered interest
	date	10/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to lower the mammogram screening age to help prevent breast cancer among younger women.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	243437
	answer	answer is ministerial correction date of answer 17/04/2019 answer text <p>There are currently no plans to lower the age of the National Health Service Breast Screening Programme, which offers all women between the ages of 50 to their 71<sup>st</sup> birthday the opportunity to be screened every three years for breast cancer.</p><p>The United Kingdom National Screening Committee awaits the publication of the Age Extension Trial which is looking at the benefits and harms of screening outside the recommended screening age. It is expected that the trial will report in 2026.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/04/2019 12:02:04 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4079 label Biography information for Julian Sturdy

1124343

	registered interest
	date	01/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Hepatitis: Disease Control
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of producing a hepatitis C elimination strategy to support the recently announced NHS England deal to help eliminate hepatitis C.
	tabling member constituency	Worthing West
	tabling member printed	Sir Peter Bottomley
	uin	249819
	answer	answer is ministerial correction date of answer 13/05/2019 answer text <p>The Government is committed to meeting the World Health Organization (WHO) target of eliminating hepatitis C by 2030 but there are no plans at this time to publish a strategy to eliminate hepatitis C. A variety of initiatives are underway in England to improve awareness and case finding, re-engagement and linkage to care, especially in drug services, primary care, prisons and accident and emergency centres. In addition, NHS England is funding access to new hepatitis C treatments in accordance with guidance from the National Institute for Health and Care Excellence (NICE).</p><p>A summary of progress towards achieving the elimination goal was published in 2017 in Public Health England’s report, ‘Hepatitis C in the UK’ at the following link:</p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/632465/HCV_in_the_uk_report_2017.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/632465/HCV_in_the_uk_report_2017.pdf</a></p><p>This showed that the United Kingdom is on target to meet the WHO interim goal of reducing hepatitis C mortality by 10% by 2020. Better access to improved treatment has led to the first fall in deaths from severe hepatitis C related liver disease in a decade.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 13/05/2019 16:08:28 answering member 4455 label Biography information for Seema Kennedy
	tabling member	117 label Biography information for Sir Peter Bottomley

1124341

	registered interest
	date	01/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Hepatitis: Primary Health Care
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve awareness of hepatitis C among primary care professionals.
	tabling member constituency	Worthing West
	tabling member printed	Sir Peter Bottomley
	uin	249817
	answer	answer is ministerial correction date of answer 13/05/2019 answer text <p>A variety of initiatives are underway in England to improve hepatitis C awareness and case finding, re-engagement and linkage to care, especially in drug services, primary care, prisons and accident and emergency centres. In addition, NHS England is funding access to new hepatitis C treatments in accordance with guidance from the National Institute for Health and Care Excellence.</p><p> </p><p>Public Health England has developed and shared materials with a range of stakeholders, including the voluntary sector, to help raise awareness of hepatitis C infection and highlight the need for those at risk to seek testing and treatment. The resources and materials available comprise of posters, a quiz, social media videos and social banners in a variety of different languages; all of these resources are available online to download or order by healthcare professionals as well as the public themselves.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 13/05/2019 15:57:09 answering member 4455 label Biography information for Seema Kennedy
	tabling member	117 label Biography information for Sir Peter Bottomley

1124342

	registered interest
	date	01/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood: Viral Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of trialling opt-out testing for (a) hepatitis C, (b) HIV and (c) other blood-borne viruses in emergency care settings.
	tabling member constituency	Worthing West
	tabling member printed	Sir Peter Bottomley
	uin	249818
	answer	answer is ministerial correction date of answer 13/05/2019 answer text <p>NHS England specialised commissioning does not run a national programme of opt-out screening within emergency care settings. NHS England is aware of some hospital trusts that have implemented an opt-out screening protocol within emergency care settings, but this is not routine practice in all hospitals. Where opt-out is implemented there are posters on display advising patients, attending the emergency department, that they will be tested unless they tell their attending clinician that they want to opt-out and do not wish to be tested.</p><p>Opportunistic testing for blood-borne diseases may also occur in non-traditional healthcare settings frequently used by people who inject drugs (or used to), such as doctors’ surgeries, community pharmacies, prisons and sexual health centres.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 13/05/2019 15:48:07 answering member 4455 label Biography information for Seema Kennedy
	tabling member	117 label Biography information for Sir Peter Bottomley

1126064

	registered interest
	date	13/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Brain: Injuries
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to establish a cross-departmental taskforce to address the issues and recommendations outlined in the report of the all-party parliamentary group on acquired brain injury entitled Acquired brain injury and neurorehabilitation - time for change.
	tabling member constituency	Wigan
	tabling member printed	Lisa Nandy
	uin	253567
	answer	answer is ministerial correction date of answer 16/05/2019 answer text <p>Officials at the Department worked with colleagues across Government to respond to recommendations of the report by the all-party parliamentary group (APPG) on acquired brain injury. This response, which outlined the broad range of activity underway to address the issues raised by the APPG, was issued on 19 February 2019. A copy of the response is attached.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 16/05/2019 15:42:08 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name DHSC APPG ABI Response.pdf title APPG Response
	tabling member	4082 label Biography information for Lisa Nandy

1123375

	registered interest
	date	26/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Antimicrobials: Drug Resistance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the uptake of (a) new and (b) underused vaccines to tackle antimicrobial resistance.
	tabling member constituency	West Lancashire
	tabling member printed	Rosie Cooper
	uin	248010
	answer	answer is ministerial correction date of answer 07/05/2019 answer text <p>‘Contained and controlled: The UK’s 20-year vision for antimicrobial resistance’ recognises the important role of vaccines in tackling antimicrobial resistance (AMR).</p><p>The United Kingdom supports the delivery and uptake of vaccines internationally through UK Aid programmes, including the Global AMR Innovation Fund, the UK Vaccine Network, Gavi, the Vaccine Alliance and the Global Vaccine Action Plan. Through these programmes UK Aid supports initiatives to ensure that all low and middle-income countries have introduced one or more new or underused vaccines by 2020.</p><p>In addition, our expert advisory committees are considering how vaccines can be better employed to support the control of AMR in the UK.</p><p>More generally, vaccinations are a key part of the prevention strategy in the NHS Long Term Plan. To help increase immunisation uptake, NHS England will undertake a fundamental review of general practitioner vaccinations and immunisation standards, funding and procurement. This will support the goal of preventing primary and secondary infections.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 07/05/2019 16:52:25 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1538 label Biography information for Rosie Cooper

1123374

	registered interest
	date	26/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pneumococcal Diseases: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect on public health of changing the dosing schedule for pneumococcal conjugate vaccine from three to two doses.
	tabling member constituency	West Lancashire
	tabling member printed	Rosie Cooper
	uin	248009
	answer	answer is ministerial correction date of answer 07/05/2019 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) advised that a two-dose schedule for the infant pneumococcal conjugate vaccine Prevenar13 is appropriate for the United Kingdom.</p><p>The JCVI’s advice was given full consideration, taking into account the potential public health implications, such as impact on cases of pneumococcal disease, before a decision was made to implement it. The decision is based on the effectiveness of the vaccine and years of high uptake, which has helped to provide protection to the rest of the population and has successfully controlled many types of pneumococcal disease in this country.</p><p>The evidence shows that two doses will sustain the excellent results we have already seen. We are confident that the world-class disease surveillance system we have in this country means our expert committee can closely monitor the impact of this change.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 07/05/2019 16:49:24 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1538 label Biography information for Rosie Cooper